79139817 - MAGLUMI

Information

  • Trademark
  • 79139817
  • Serial Number
    79139817
  • Registration Number
    4683169
  • Filing Date
    July 17, 2013
    11 years ago
  • Registration Date
    February 10, 2015
    9 years ago
  • Transaction Date
    January 25, 2025
    6 days ago
  • Status Date
    May 02, 2022
    2 years ago
  • Published for Opposition Date
    November 25, 2014
    10 years ago
  • Location Date
    May 02, 2022
    2 years ago
Mark Drawing Code
5
Mark Identification
MAGLUMI
Case File Statements
  • DM0000: The mark consists of the stylized words "MAGLUMI".
  • GS0051: Drugs for medical purposes for treatment of tumors, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, TORCH infections and immunoglobulin disease; medicated serums for invitro diagnosis and treatment; medicated serums for in-vivo diagnosis and treatment; serotherapeutic medicines; cultures of microorganisms for medical and veterinary use; biological preparations for pharmaceutical purposes for treatment of tumors, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, TORCH infections and immunoglobulin diseases; chemical preparations for pharmaceutical purposes, namely, for diagnosis or treatment of tumors, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, TORCH infections and immunoglobulin diseases; Diagnostic preparations for medical purposes, namely, for diagnosing or detecting tumors, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, TORCH infections and immunoglobulin diseases; enzymes for medical purposes; enzyme preparations for medical purposes; chemical preparations for the diagnosis of pregnancy
  • CC0000: Color is not claimed as a feature of the mark.
  • TR0010: The wording "MAGLUMI" has no meaning in a foreign language.
  • GS0101: Blood testing apparatus; [ massage apparatus; ] apparatus for use in medical analysis, namely, medical analyzer for analysis of blood samples, body fluids and body tissue samples; testing apparatus for medical purposes, namely, medical testing instrument for testing blood samples, body fluids and body tissue samples; diagnostic apparatus for medical purposes, namely, medical diagnostic analyzer for analyzing blood samples, body fluids and body tissue samples; radiotherapy apparatus; ultrasonic devices and parts thereof for medical use, namely, clinical ultrasonic diagnostic apparatus and parts thereof [ ; artificial limbs; multifunction corsets for medical purpose, namely, diagnosis and therapeutic corsets for medical purpose; suture materials ]
Case File Event Statements
  • 12/18/2013 - 11 years ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 12/12/2013 - 11 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 12/14/2013 - 11 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 12/14/2013 - 11 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 12/20/2013 - 11 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 12/21/2013 - 11 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 12/30/2013 - 11 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 12/30/2013 - 11 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 1/17/2014 - 11 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 3/17/2014 - 10 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/28/2014 - 10 years ago
    11 - ASSIGNED TO LIE Type: ALIE
  • 4/8/2014 - 10 years ago
    12 - ASSIGNED TO LIE Type: ALIE
  • 4/17/2014 - 10 years ago
    13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/17/2014 - 10 years ago
    14 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 5/26/2014 - 10 years ago
    15 - FINAL REFUSAL WRITTEN Type: CNFR
  • 5/27/2014 - 10 years ago
    16 - FINAL REFUSAL MAILED Type: CNFR
  • 10/13/2014 - 10 years ago
    17 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 10/13/2014 - 10 years ago
    18 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/14/2014 - 10 years ago
    19 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/22/2014 - 10 years ago
    20 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 10/22/2014 - 10 years ago
    21 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 10/22/2014 - 10 years ago
    22 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 10/22/2014 - 10 years ago
    23 - EXAMINERS AMENDMENT MAILED Type: CNEA
  • 10/23/2014 - 10 years ago
    24 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 11/5/2014 - 10 years ago
    25 - NOTICE OF PUBLICATION Type: NPUB
  • 11/25/2014 - 10 years ago
    26 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 1/3/2015 - 10 years ago
    27 - CORRECTION TRANSACTION RECEIVED FROM IB Type: CRCV
  • 1/13/2015 - 10 years ago
    28 - CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED Type: CORN
  • 2/10/2015 - 9 years ago
    29 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 5/10/2015 - 9 years ago
    30 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 6/11/2015 - 9 years ago
    31 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 6/11/2015 - 9 years ago
    32 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 6/27/2015 - 9 years ago
    33 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 11/26/2015 - 9 years ago
    34 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH
  • 2/20/2020 - 4 years ago
    35 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH
  • 2/7/2021 - 3 years ago
    36 - TEAS SECTION 71 RECEIVED Type: ES71
  • 3/4/2021 - 3 years ago
    37 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 3/11/2021 - 3 years ago
    38 - POST REGISTRATION ACTION MAILED - SEC.71 Type: PR71
  • 10/15/2021 - 3 years ago
    39 - CANCELLED SECTION 71 Type: C71T
  • 10/16/2021 - 3 years ago
    40 - NOTICE OF CANCELLATION SEC. 71 E-MAILED Type: NC71
  • 10/25/2021 - 3 years ago
    41 - REINSTATED Type: REIN
  • 10/25/2021 - 3 years ago
    42 - POST REGISTRATION ACTION MAILED - SEC.71 Type: PR71
  • 10/27/2021 - 3 years ago
    43 - POST REGISTRATION ACTION MAILED - SEC.71 Type: PR71
  • 11/19/2021 - 3 years ago
    44 - TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED Type: EROP
  • 5/2/2022 - 2 years ago
    45 - REGISTERED-SEC.71 ACCEPTED Type: 71AG
  • 5/2/2022 - 2 years ago
    46 - NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED Type: NA71
  • 1/2/2023 - 2 years ago
    47 - PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INPR
  • 2/22/2023 - a year ago
    48 - GENERIC MADRID TRANSACTION CREATED Type: XXCR
  • 2/22/2023 - a year ago
    49 - GENERIC MADRID TRANSACTION SENT TO IB Type: XXSS
  • 4/12/2023 - a year ago
    50 - PARTIAL INVALIDATION PROCESSED BY THE IB Type: INNP
  • 1/24/2025 - 7 days ago
    53 - TEAS SECTION 71 RECEIVED Type: ES71
  • 2/10/2024 - 11 months ago
    52 - COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED Type: REM4
  • 5/12/2023 - a year ago
    51 - INTERNATIONAL REGISTRATION RENEWED Type: RNWL